748
Views
3
CrossRef citations to date
0
Altmetric
Original Article

The pitfalls of prevalence estimation: the case of regular and dependent methamphetamine use in Australia

, , , , &
Pages 439-446 | Received 07 Jul 2017, Accepted 02 Oct 2017, Published online: 10 Apr 2018

References

  • Australian Bureau of Statistics. (2016). Quarterly Population Estimates (ERP), by State/Territory, Sex and Age. http://stat.abs.gov.au/index.aspx?queryid = 396
  • Australian Crime Commission. (2015). 2013–14 Illicit Drug Data Report. Canberra: Australian Crime Commission.
  • Australian Institute of Health and Welfare. (2013). Alcohol and other drug treatment services in Australia 2011-12. Drug treatment series 21. Cat. no. HSE139. Canberra: Australian Institute of Health and Welfare.
  • Australian Institute of Health and Welfare. (2014a). Alcohol and other drug treatment and diversion from the Australian criminal justice system: 2012-13. Cat. no. AUS186. Canberra: Australian Institute of Health and Welfare.
  • Australian Institute of Health and Welfare. (2014b). National Drug Strategy Household Survey detailed report 2013. (Vol. AIHW cat. no. PHE183). Canberra: Australian Institute of Health and Welfare.
  • Australian Institute of Health and Welfare. (2015). Alcohol and other drug treatment services in Australia 2013-14. Drug treatment series no. 25. Cat. no. HSE 158. Canberra: AIHW.
  • Australian Institute of Health and Welfare. (2017). National Drug Strategy Household Survey (NDSHS) 2016 key findings
  • Degenhardt L, Larney S, Chan G, Dobbins T, Weier M, Roxburgh A, Hall WD, McKetin R. 2016. Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014. Med J Aust. 204:153.
  • Degenhardt L, Rendle V, Hall W, Gilmour S, Law W. (2004). Estimating the number of current regular heroin users in New South Wales and Australia 1997-2002 (NDARC Technical Report No. 198). Sydney: National Drug and Alcohol Research Centre.
  • Degenhardt L, Sara G, McKetin R, Roxburgh A, Dobbins T, Farrell M, Burns L, Hall WD. 2017. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug Alcohol Rev. 36:160–170.
  • Dietze PM, Quinn B, Hughes C. 2016. Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014. Med J Aust. 205:425–426.
  • Frischer M, Hickman M, Kraus L, Mariani F, Wiessing L. 2001. A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain. Addiction. 96:1465–1476.
  • Gray SD, Fatovich DM, McCoubrie DL, Daly FF. 2007. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust. 186:336–339.
  • Hall W, Ross J, Lynskey M, Law M, Degenhardt L. (2000). How many dependent opioid users are there in Australia? National drug and alcohol research centre monograph No. 44. Sydney: University of NSW.
  • Horyniak D, Degenhardt L, Smit de V, Munir V, Johnston J, Fry C, Dietze P. 2014. Pattern and characteristics of ecstasy and related drug (ERD) presentations at two hospital emergency departments, Melbourne, Australia, 2008-2010. Emerg Med J. 31:317–322.
  • Hser Y-I. 1993. Prevalence estimation: Summary of common problems and practical solutions. J Drug Issues. 23:335–343.
  • Kozaki D. (2016). Methamphetamine use in Australia tripled in past five years, research shows. Available at http://www.abc.net.au/news/2016-02-29/trippling-in-methamphetamine-use-australia-five-years/7207012
  • Kraus L, Augustin R, Frischer M, Kummler P, Uhl A, Wiessing L. 2003. Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction. 98:471–485.
  • Lim MS, Cogger S, Quinn B, Hellard ME, Dietze PM. 2015. 'Ice epidemic'? Trends in methamphetamine use from three Victorian surveillance systems. Aust N Z J Public Health. 39:194–195.
  • McKetin R. 2016. Will the Australian Government's response to its 'National Ice Taskforce' deliver more treatment as promised?. Drug Alcohol Rev. 35:247–249.
  • McKetin R, Dean OM, Baker AL, Carter G, Turner A, Kelly PJ, Berk M. 2017. A potential role for N-acetylcysteine in the management of methamphetamine dependence. Drug Alcohol Rev. 36:153–159.
  • McKetin R, McLaren J, Kelly E, Hall W, Hickman M. (2005). Estimating the Number of Regular and Dependent Methamphetamine Users in Australia. NDARC Technical Report No. 230. Sydney: National Drug and Alcohol Research Centre.
  • Office of Senator the Hon Fiona Nash. (2016). Figures reveal Ice Taskforce was the right call: Media Release available at http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2016-nash007.htm.
  • Quinn B, Stoove M, Papanastasiou C, Dietze P. 2013. Methamphetamine use in Melbourne, Australia: baseline characteristics of a prospective methamphetamine-using cohort and correlates of methamphetamine dependence. J Subst Use. 18:349–362.
  • Sara GE, Burgess PM, Harris MG, Malhi GS, Whiteford HA. 2011. Stimulant use and stimulant use disorders in Australia: findings from the National Survey of Mental Health and Wellbeing. Med J Aust. 195:607–609.
  • Scott N, Caulkins JP, Ritter A, Quinn C, Dietze P. 2015. High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia. Addiction. 110:120–128.
  • Stafford J, Burns L. (2015). Australian drug trends 2014: findings from the Illicit Drug Reporting System (IDRS). Australian Drug Trends Series no. 127. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
  • Stimson G, Hickman M, Quirk A, Frischer M, Taylor C. (1997). Estimating the prevalence of problem drug use in Europe. Luxembourg: Office for Official Publications of the European Communities.
  • Sullivan C, Staib A, Khanna S, Good NM, Boyle J, Cattell R, Heiniger L, Griffin BR, Bell AJ, Lind J, Scott IA. 2016. The National Emergency Access Target (NEAT) and the 4-hour rule: time to review the target. Med J Aust. 204:354.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.